Credit Suisse’s EyePoint Pharmaceuticals EYPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | $851K | Buy |
+41,152
| New | +$851K | ﹤0.01% | 2357 |
|
|
2023
Q1 | – | Sell |
-1
| Closed | -$4 | – | 3404 |
|
|
2022
Q4 | $4 | Sell |
1
-146
| -99% | -$584 | ﹤0.01% | 3824 |
|
|
2022
Q3 | $1K | Buy |
147
+121
| +465% | +$823 | ﹤0.01% | 3825 |
|
|
2022
Q2 | $0 | Buy |
+26
| New | – | ﹤0.01% | 4020 |
|
|
2019
Q4 | – | Sell |
-1,442
| Closed | -$26K | – | 3501 |
|
|
2019
Q3 | $26K | Buy |
1,442
+393
| +37% | +$7.09K | ﹤0.01% | 3405 |
|
|
2019
Q2 | $17K | Buy |
+1,049
| New | +$17K | ﹤0.01% | 3402 |
|
|
2017
Q1 | – | Sell |
-2,279
| Closed | -$39K | – | 3472 |
|
|
2016
Q4 | $39K | Sell |
2,279
-315
| -12% | -$5.39K | ﹤0.01% | 3674 |
|
|
2016
Q3 | $78K | Sell |
2,594
-2,650
| -51% | -$79.7K | ﹤0.01% | 3620 |
|
|
2016
Q2 | $148K | Sell |
5,244
-1,143
| -18% | -$32.3K | ﹤0.01% | 3663 |
|
|
2016
Q1 | $172K | Buy |
+6,387
| New | +$172K | ﹤0.01% | 3425 |
|
|
2015
Q1 | – | Sell |
-1,100
| Closed | -$45K | – | 4090 |
|
|
2014
Q4 | $45K | Buy |
+1,100
| New | +$45K | ﹤0.01% | 4141 |
|